- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Role of pelvic lymph node dissection in prostate cancer treatment - Abstract
September 15, 2011
Prostate-specific antigen testing across the spectrum of prostate cancer - Abstract
September 15, 2011
Active-targeted nanotherapy strategies for prostate cancer - Abstract
September 15, 2011
Transrectal implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT - Abstract
September 14, 2011
T2*-weighted image/T2-weighted image fusion in postimplant dosimetry of prostate brachytherapy - Abstract
September 14, 2011
Assessing the impact of comorbid illnesses on death within 10 years in prostate cancer treatment candidates - Abstract
September 14, 2011
End points and outcomes in castration-resistant prostate cancer: From clinical trials to clinical practice - Abstract
September 14, 2011
Androgen receptor rediscovered: The new biology and targeting the androgen receptor therapeutically - Abstract
September 14, 2011
The combination of Serenoa repens, selenium and lycopene is more effective than Serenoa repens alone to prevent hormone dependent prostatic growth - Abstract
September 14, 2011
Association between saliva PSA and serum PSA in conditions with prostate adenocarcinoma - Abstract
September 13, 2011
Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer - Abstract
September 13, 2011
The role of transperineal template prostate biopsies in restaging men with prostate cancer managed by active surveillance - Abstract
September 13, 2011
New treatment options for castrate-resistant prostate cancer: A urology perspective - Abstract
September 13, 2011
Cross validation of the prostate cancer radiotherapy late toxicity (PCRT) questionnaire with the expanded prostate cancer index composite (EPIC) instrument - Abstract
September 13, 2011